- Home
- DOW vs IQV Comparison
DOW vs IQV Comparison
Compare DOW & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOW | IQV |
|---|---|---|
| Founded | 1897 | 1982 |
| Country | United States | United States |
| Employees | 35700 | 93000 |
| Industry | Major Chemicals | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0B | 28.6B |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | DOW | IQV |
|---|---|---|
| Price | $38.66 | $170.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 16 |
| Target Price | $39.13 | ★ $227.13 |
| AVG Volume (30 Days) | ★ 11.5M | 1.6M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.54% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 1.61 |
| Revenue | ★ $39,968,000,000.00 | $9,739,000,000.00 |
| Revenue This Year | $5.40 | $6.77 |
| Revenue Next Year | $2.33 | $5.89 |
| P/E Ratio | ★ N/A | $107.40 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $20.40 | $134.65 |
| 52 Week High | $42.74 | $247.05 |
Technical Indicators
Market Signals| Indicator | DOW | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 50.05 | 50.72 |
| Support Level | $35.37 | $159.08 |
| Resistance Level | $42.11 | $172.80 |
| Average True Range (ATR) | 1.35 | 6.66 |
| MACD | -0.15 | 0.94 |
| Stochastic Oscillator | 40.17 | 59.43 |
Price Performance
Historical ComparisonAbout DOW Dow Inc.
Dow Chemical is a diversified global chemicals producer formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in consumer and industrial end markets.
About IQV IQVIA Holdings Inc.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.